{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T16:08:50Z","timestamp":1785686930701,"version":"3.56.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"30","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taiho Oncology Inc"},{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.2217\/fon-2022-0305","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T10:51:17Z","timestamp":1661856677000},"page":"3377-3387","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["A phase II Study of TAS-117 in Patients with Advanced Solid Tumors Harboring Germline\n            <i>PTEN<\/i>\n            -Inactivating Mutations"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-3632","authenticated-orcid":false,"given":"Jordi","family":"Rod\u00f3n","sequence":"first","affiliation":[{"name":"Department of Investigational Cancer Therapeutics,Division of Cancer Medicine,MD Anderson Cancer Center,\rHouston,\rTX 77030,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-8626","authenticated-orcid":false,"given":"Pauline","family":"Funchain","sequence":"additional","affiliation":[{"name":"Cleveland Clinic,\rCleveland,\rOH 44195,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8497-3138","authenticated-orcid":false,"given":"Theodore W","family":"Laetsch","sequence":"additional","affiliation":[{"name":"Children\u2018s Hospital of Philadelphia,&amp; University of Pennsylvania,\rPhiladelphia,\rPA 19104,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2015-1549","authenticated-orcid":false,"given":"Hendrik-Tobias","family":"Arkenau","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, London, UK, &amp; Cancer Institute,University College London,\rLondon,\rW1G 6AD,\rUK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hervieu","sequence":"additional","affiliation":[{"name":"Centre Georges-Fran\u00e7ois Leclerc,\rDijon,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-0027","authenticated-orcid":false,"given":"Christian F","family":"Singer","sequence":"additional","affiliation":[{"name":"Dept of OB\/GYN &amp; Comprehensive Cancer Center,Medical University of Vienna,\rVienna,\r1090,\rAustria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9027-2891","authenticated-orcid":false,"given":"Yonina R","family":"Murciano-Goroff","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center,\rNew York City,\rNY 10065,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant P","family":"Chawla","sequence":"additional","affiliation":[{"name":"Sarcoma Oncology Research Center,\rSanta Monica,\rCA 90403,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3268-346X","authenticated-orcid":false,"given":"Kristin","family":"Anthony","sequence":"additional","affiliation":[{"name":"The PTEN Hamartoma Tumor Syndrome Foundation,\rHuntsville,\rAL 35806,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Yamamiya","sequence":"additional","affiliation":[{"name":"Taiho Oncology,\rPrinceton,\rNJ 08540,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Taiho Oncology,\rPrinceton,\rNJ 08540,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Baset","family":"Halim","sequence":"additional","affiliation":[{"name":"Taiho Oncology,\rPrinceton,\rNJ 08540,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9883-6970","authenticated-orcid":false,"given":"Karim A","family":"Benhadji","sequence":"additional","affiliation":[{"name":"Taiho Oncology,\rPrinceton,\rNJ 08540,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Taiho Oncology,\rPrinceton,\rNJ 08540,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-9165","authenticated-orcid":false,"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[{"name":"Institut Gustave Roussy,\rVillejuif,\r94805,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0954-x"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0891"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.01.012"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.662232"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0216-7"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0015-0"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121277"},{"key":"e_1_3_5_10_1","first-page":"PO.19.00130","article-title":"Exceptional response to AKT inhibition in patients with breast cancer and germline PTEN mutations","volume":"3","author":"Kingston B","year":"2019","unstructured":"Kingston B , BailleuxC, DelalogeSet al. Exceptional response to AKT inhibition in patients with breast cancer and germline PTEN mutations. JCO Precis. Oncol.3, PO.19.00130 (2019).","journal-title":"JCO Precis. Oncol."},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911407325"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2283"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13875"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt277"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-0651-7"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0001"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.04.002"},{"key":"e_1_3_5_18_1","volume-title":"StatPearls.","author":"Garofola C","year":"2021","unstructured":"Garofola C , JamalZ, GrossGP. Cowden disease. In: StatPearls.StatPearls Publishing, FL, USA (2021)."},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a006134"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(12)72154-8"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(12)72153-6"},{"key":"e_1_3_5_22_1","unstructured":"Taiho Oncology Ltd\n. Data on file (2021)."},{"issue":"5","key":"e_1_3_5_23_1","first-page":"v159","article-title":"First-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors","volume":"30","author":"Yunokawa M","year":"2019","unstructured":"Yunokawa M et al. First-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors. Ann. Oncol.30(Suppl. 5), v159\u2013v193 (2019).","journal-title":"Ann. Oncol."},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-021-01085-7"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0588-1"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.6656"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0365"},{"key":"e_1_3_5_28_1","unstructured":"US Food and Drug Administration\n. Considerations for the inclusion of adolescent patients in adult oncology clinical trials guidance for industry. (2019). http:\/\/www.fda.gov\/media\/113499\/download"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.465"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040435"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1210-4"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1154-8"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3196-6"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2022-0305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:23Z","timestamp":1719125183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2022-0305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":31,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.2217\/fon-2022-0305"],"URL":"https:\/\/doi.org\/10.2217\/fon-2022-0305","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}